Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net loss	$ (33,309,533)	$ (81,010,501)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation expense	2,604,291	9,750,110
Depreciation and amortization	2,743,648	2,686,779
Changes in acquisition-related contingent consideration	0	(18,260,000)
Impairment of goodwill and intangible assets	0	62,273,336
Loss on disposal of assets	591,307	0
Deferred income taxes	138,038	(17,243,528)
Amortization/Accretion on Marketable Securities	0	95,095
Changes in operating assets and liabilities:
Prepaid and other current assets	6,245	872,990
Accounts receivable	(325,622)	545,173
Deferred costs	(670,555)	(344,753)
Unearned revenues	4,340,366	1,011,104
Other assets	262,830	286,607
Accounts payable, accrued liabilities and other liabilities	(48,697)	79,257
Net cash used in operating activities	(23,667,682)	(39,258,331)
Cash flows from investing activities:
Purchase of short term investments	0	(6,081,900)
Sales of marketable securities	0	13,066,014
Acquisition of property and equipment	(2,849,296)	(3,185,737)
Net cash (used in) provided by investing activities	(2,849,296)	3,798,377
Cash flows from financing activities:
Payments Related to Tax Withholding for Share-based Compensation	(72,010)	0
Net proceeds from issuance of capital stock	11,560,394	36,471,269
Repayments of Long-term Debt	(9,348,646)	0
Proceeds from notes payable	979,579	1,087,361
Repayment of notes payable	1,615,742	954,326
Sale of ownership interest in subsidiary	(19,400,000)	0
Net cash provided by financing activities	20,903,575	36,604,304
Net (decrease) increase in cash and cash equivalents	(5,613,403)	1,144,350
Cash and cash equivalents at beginning of year	20,318,411	19,174,061
Cash and cash equivalents at end of year	14,705,008	20,318,411
Cash paid during the period for:
Interest	1,823,424	1,497,845
Taxes	$ 0	$ 0